汇宇制药(688553)5月11日晚间公告,因自身资金需求,股东上海爽飒拟通过集中竞价或大宗交易的方式减持公司股份不超过12,695,629股,合计减持股份比例不超过公司股份总数的2.997%。减持期间为自本公告披露之日起15个交易日后的3个月内。截至公告披露之日,公司股东上海爽飒持有公司股份数量为12,695,629股。这意味着,如果上海爽飒顶格减持,将清仓所持汇宇制药全部股份。汇宇制药2024...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.